Safety of Simparica Trio® (sarolaner, pyrantel, moxidectin) in heartworm-infected dogs
Abstract Background Assessment of the safety of heartworm preventatives in dogs with pre-existing patent heartworm (Dirofilaria immitis) infections is necessary because rapid adult worm and microfilarial death can lead to severe clinical complications, including thromboembolism and anaphylactic shoc...
Main Authors: | Sheerin Mathur, Phyllis B. Malpas, Sean Mahabir, Joseph Boucher, Aleah Pullins, Genevieve Gagnon, Tom L. McTier, Steven Maeder |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | Parasites & Vectors |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13071-023-05700-9 |
Similar Items
-
Efficacy of a formulation of sarolaner/moxidectin/pyrantel (Simparica Trio®) for the prevention of Thelazia callipaeda canine eyeworm infection
by: Marcos Antonio Bezerra-Santos, et al.
Published: (2022-10-01) -
Efficacy of a chewable tablet containing sarolaner, moxidectin, and pyrantel (Simparica Trio®) in the treatment of sarcoptic mange caused by Sarcoptes scabiei mite infestations in dogs
by: Csilla Becskei, et al.
Published: (2023-11-01) -
Field safety and efficacy of an orally administered combination of sarolaner, moxidectin and pyrantel (Simparica Trio®) for the prevention of angiostrongylosis in dogs presented as veterinary patients
by: Csilla Becskei, et al.
Published: (2020-07-01) -
Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs
by: Tom L. McTier, et al.
Published: (2019-09-01) -
Successful Removal of <i>Angiostrongylus cantonensis</i> Larvae from the Central Nervous System of Rats 7- and 14-Days Post-Infection Using a Product Containing Moxidectin, Sarolaner and Pyrantel Embonate (Simparica Trio™) in Experimental Infections
by: Michaela Henry, et al.
Published: (2023-02-01)